4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000030
CEO sold 3,000 shares at an average $15.04 ($45,129)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal CEO | 2024-05-16 | Sale 10b5-1 | −1,800 | $15.00 | $27,000 | 338,575 | D |
| Doshi Dipal CEO | 2024-05-17 | Sale 10b5-1 | −1,200 | $15.11 | $18,129 | 337,375 | D |
| Open-market sales · 3,000 sh · avg $15.04 · $45,129 | |||||||
Loading xslF345X05/wk-form4_1716240109.xml…